A breakthrough in internal competition I A new generation of rapid fluorescence quantitative PCR system is approved for marketing

Pangu, a new generation of rapid fluorescent PCR detection applications

In 2020, the COVID-19 pandemic promoted the public's awareness of nucleic acid testing and the development of my country's second-generation PCR, which has basically achieved domestic substitution. However, judging from the various PCR instruments on the market, many so-called rapid PCR instruments mostly pursue the so-called rapid temperature rise and fall under the premise of miniaturization of detection flux, but basically sacrifice the stability and uniformity of temperature, facing serious product homogeneity and uneven quality of various products.

Compared with the aforementioned PCR products, Pangu is a rapid fluorescent quantitative PCR instrument that can process 96 samples at a time, with a detection time of ≤30 mins. Fast heating, fast detection, fast start-up, sensitive and stable are the rare signs of it as a new generation of models.

Product performance of Pangu

The Pangu (pangaea) rapid fluorescent quantitative PCR system achieves ultra-fast running time, higher detection sensitivity, more sensitive signal acquisition, and high uniformity and repeatability with its unique temperature control and optical waveguide optical detection design. The intelligent operation process brings a friendly operation experience to scientific research and clinical users.

Pangu, bringing you a one-machine-multi-use experience

Driven by the collaborative innovation and development of industry, academia, research and medicine, the application function characteristics of Pangu equipment at the scientific research level can easily meet the early exploratory research applications of scientific researchers or IVD developers. Therefore, whether for scientific researchers or IVD developers, using Pangu's platform can directly achieve a seamless transition from scientific research to product development tests, without having to consider the reselection of IVD reagent adapter models and the problem of adaptation tests, reducing and saving the time and cost of product commercialization, and helping the transformation and application of scientific research to industrialization.

Pangu Value - Enabling High-quality Development of IVD Reagents

The performance indicators of IVD detection kits are important criteria for evaluating their effectiveness and reliability. These indicators include sensitivity, specificity and accuracy, and the data results of these indicators must be presented on the matching equipment. It can be seen that the quality of reagent performance does not only represent the results of the reagent itself, but also complements the performance of the equipment. It is the result of the comprehensive presentation of instrument performance and reagent performance. Therefore, in the comparative test of reagents, we often find that the same reagent presents different performance results on different test equipment platforms.

Especially now that the demand for the development of multiple detection products is increasing, the sensitivity of various detection targets, fluorescence crosstalk between different channels and other factors are all problems that designers and developers need to face and solve; in addition to the technical requirements of the product itself, the design and development of some complex sample type detection or higher technical requirements products have higher requirements for the temperature control and stability of the instrument. Pangu, whether in different comparative tests of multi-dimensional indicators such as detection timeliness, performance stability and reagent sensitivity, Pangu has presented relatively excellent comparative results.

A stable and reliable instrument platform is a favorable booster for reagent developers, which can avoid problems in reagent development caused by instrument platform factors, or even the failure of reagent development, and promote the development progress of products and the improvement of product reagent performance.

Strive to be a new quality productivity service provider and open cooperation platform

New quality productivity represents the evolution direction of advanced productivity, which is an advanced productivity quality state spawned by revolutionary technological breakthroughs, innovative configuration of production factors, and deep transformation and upgrading of industries. Apbai insists on taking new quality productivity as the development direction, providing innovative and high-quality products and services, and coordinating with partners from all parties to carry out extensive cooperation based on the company's platform and technology applications.

About Apbai Bio

Aapbai Biotechnology (Suzhou) Co., Ltd. is a high-tech enterprise and a leading talent enterprise in Suzhou. It innovates life science research tools and medical diagnostic products, focuses on the research and development of cutting-edge life science technologies and their application transformation in the field of personalized medicine, strategically deploys domestic and overseas markets, and adheres to providing solutions and services for life science research and clinical diagnosis. The company has passed ISO13485 and ISO9001 quality system certification. The R&D team is led by a number of returned doctors. They have a solid foundation and rich experience in hardware and software such as molecular biology research and experimental technology. They have undertaken a number of technical research and development projects and obtained a number of national authorized patents and software copyrights related to nucleic acid trace detection and digital PCR detection. The company has built a research and development platform for instruments and technologies such as digital PCR, rapid fluorescence quantitative PCR, and microscopic imaging acquisition and analysis, and can sustainably develop a series of molecular diagnostic products in multiple fields such as disease-related molecular and cytogenetic detection and targeted drug guidance. Since its establishment, the company has won wide recognition and support from customers with its professional products and services.